1. Home
  2. NRXP vs FMST Comparison

NRXP vs FMST Comparison

Compare NRXP & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • FMST
  • Stock Information
  • Founded
  • NRXP 2015
  • FMST 2005
  • Country
  • NRXP United States
  • FMST Canada
  • Employees
  • NRXP N/A
  • FMST N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • FMST Other Metals and Minerals
  • Sector
  • NRXP Health Care
  • FMST Basic Materials
  • Exchange
  • NRXP Nasdaq
  • FMST Nasdaq
  • Market Cap
  • NRXP 48.5M
  • FMST 16.8M
  • IPO Year
  • NRXP N/A
  • FMST N/A
  • Fundamental
  • Price
  • NRXP $4.01
  • FMST $1.40
  • Analyst Decision
  • NRXP Strong Buy
  • FMST
  • Analyst Count
  • NRXP 3
  • FMST 0
  • Target Price
  • NRXP $31.67
  • FMST N/A
  • AVG Volume (30 Days)
  • NRXP 2.8M
  • FMST 19.4K
  • Earning Date
  • NRXP 11-14-2024
  • FMST 01-01-0001
  • Dividend Yield
  • NRXP N/A
  • FMST N/A
  • EPS Growth
  • NRXP N/A
  • FMST N/A
  • EPS
  • NRXP N/A
  • FMST N/A
  • Revenue
  • NRXP N/A
  • FMST N/A
  • Revenue This Year
  • NRXP N/A
  • FMST N/A
  • Revenue Next Year
  • NRXP N/A
  • FMST N/A
  • P/E Ratio
  • NRXP N/A
  • FMST N/A
  • Revenue Growth
  • NRXP N/A
  • FMST N/A
  • 52 Week Low
  • NRXP $1.10
  • FMST $1.32
  • 52 Week High
  • NRXP $7.33
  • FMST $3.50
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 61.48
  • FMST 43.67
  • Support Level
  • NRXP $3.20
  • FMST $1.32
  • Resistance Level
  • NRXP $6.01
  • FMST $1.43
  • Average True Range (ATR)
  • NRXP 0.95
  • FMST 0.09
  • MACD
  • NRXP 0.11
  • FMST 0.01
  • Stochastic Oscillator
  • NRXP 56.52
  • FMST 28.57

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About FMST Foremost Lithium Resource & Technology Ltd. Common stock

Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with significant historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec.

Share on Social Networks: